NCT07468864

Brief Summary

This study was planned to examine the validity and reliability of the Turkish version of the Situational Vertigo Questionnaire (SVQ), which is used to evaluate dizziness symptoms frequently seen in vestibular pathologies and triggered by visual or environmental stimuli. The research is designed as a methodological scale adaptation and psychometric evaluation study. The study plans to include individuals aged 18 and over who can read and understand Turkish and have complaints of situational dizziness. The Turkish adaptation process of the SVQ will be carried out using the back-and-forth translation method; a pilot application will be conducted after ensuring linguistic and cultural equivalence. For the psychometric evaluation, the sample size is planned to be at least 10 times the number of items, and participants will be asked to complete the SVQ, as well as the Dizziness Handicap Inventory (DHI), Vertigo Symptom Scale (VSS), and Visual Analog Scale (VAS). To evaluate test-retest reliability, a subgroup of participants will be re-administered the SVQ after 7 days. No invasive procedures will be performed on participants during the research; only survey forms will be used. Written informed consent will be obtained from all participants, and data will be coded and analyzed in accordance with confidentiality principles. It is expected that the findings of this study will contribute to the literature by establishing a valid and reliable measurement tool in Turkish for the evaluation of situational dizziness symptoms and will support clinical evaluation processes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for all trials

Timeline
6mo left

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Feb 2026Feb 2027

Study Start

First participant enrolled

February 16, 2026

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2026

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

March 9, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 13, 2026

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2027

Expected
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

14 days

First QC Date

March 9, 2026

Last Update Submit

March 9, 2026

Conditions

Keywords

situational vertigo questionnairevalidityreliabilityvestibular pathology

Outcome Measures

Primary Outcomes (1)

  • Situational Vertigo Questionnaire (SVQ)

    The Situational Vertigo Questionnaire (SVQ) is a 19-item self-report scale designed to assess visual vertigo associated with increased visual dependence and insufficient vestibular compensation. Visual vertigo refers to dizziness triggered or worsened in visually complex or disorienting environments such as supermarkets, driving, or moving visual scenes. The condition is thought to arise from difficulties resolving conflicts between visual, vestibular, and proprioceptive inputs. The SVQ asks individuals to rate the severity of dizziness in situations involving visual motion or visual-vestibular conflict. Each item is scored from 0 (none) to 4 (severe), and participants may select "never experienced" if applicable. The total score is calculated based on the average item score, adjusted for items marked as not experienced, with higher scores indicating more severe symptoms.

    Baseline and 7-14 days follow-up

Secondary Outcomes (2)

  • Dizziness Handicap Inventory (DHI)

    Baseline and 7-14 days follow-up

  • Vertigo Symptom Scale (VSS)

    Baseline and 7-14 days follow-up

Other Outcomes (1)

  • Participant Satisfaction/Visual Analog Scale (VAS)

    Baseline and 7-14 days follow-up

Study Arms (1)

Vestibular Patients

The target population of this study consists of individuals aged 18 years and older who can read and understand Turkish and experience dizziness triggered by visual or environmental stimuli. Written informed consent will be obtained from all participants. Sociodemographic and clinical characteristics, including age, sex, occupation, smoking and alcohol use, comorbidities, medical history, medications, daily activity level, onset and type of the condition, fall history, and sensitivity to heights, darkness, and crowded environments, will be recorded using a researcher-designed form. Based on the "item number × 10" rule, at least 190 participants will be included for the 19-item Situational Vertigo Questionnaire (SVQ). Participants will complete the SVQ, Dizziness Handicap Inventory (DHI), and Vertigo Symptom Scale (VSS), and rate satisfaction using a Visual Analog Scale. Test-retest reliability will be assessed in at least 20% of participants after 7-14 days.

Other: validity and reliability

Interventions

The Turkish adaptation of the Situational Vertigo Questionnaire (SVQ) will follow internationally accepted cross-cultural adaptation guidelines using a forward-backward translation method. Two independent bilingual translators will translate the original English version into Turkish, producing two versions that will be compared and synthesized into a preliminary Turkish form. This version will then be back-translated into English by two native English speakers blinded to the original scale. A committee of translators and experts will review all versions to ensure conceptual and linguistic equivalence and create a pre-final Turkish version. The pre-final version will be pilot tested with 20 participants to assess clarity and comprehension. Items reported as unclear will be revised. Finally, the scale will be administered to a larger sample for psychometric evaluation of validity and reliability.

Vestibular Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Frequent complaints of dizziness and imbalance in vestibular pathologies are significant clinical problems that negatively affect individuals' daily life activities, social participation, and quality of life. In particular, valid and reliable measurement tools reflecting the individual's subjective experience are needed in the evaluation of situational dizziness symptoms triggered by visual or environmental stimuli. In this context, the Situational Vertigo Questionnaire (SVQ), widely used in the international literature, stands out as an important tool in the evaluation of dizziness symptoms associated with situational and visual stimuli.

You may qualify if:

  • Presence of dizziness triggered by visual or environmental stimuli
  • Able to read and write Turkish
  • Voluntary agreement to participate in the study
  • Having the mental capacity to give informed consent (Mini Mental State Scale score ≥ 24)

You may not qualify if:

  • Individuals with severe cognitive impairment or communication difficulties
  • Acute neurological disease (stroke, acute MS relapse, etc.)
  • Having undergone vestibular surgery within the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Güneşli Erdem Hastanesi

Bağcılar, Güneşli, 34200, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Reproducibility of Results

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesEvaluation Studies as TopicHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist Physiotherapist

Study Record Dates

First Submitted

March 9, 2026

First Posted

March 13, 2026

Study Start

February 16, 2026

Primary Completion

March 2, 2026

Study Completion (Estimated)

February 20, 2027

Last Updated

March 13, 2026

Record last verified: 2026-03

Locations